Since the seminal work of Oates (1972) on fiscal federalism, a central question of public finance has been which level of a federation should be assigned the provision of public goods. In this paper we study the problem of a government that is to choose the optimal...

We study the welfare properties of direct restrictions based on cost-effectiveness against indirect methods represented by waiting lists in a public health care system. Health care is supplied for free, but with some restrictions by the public health sector. Patients can choose to address their...

Drug price regulation is acquiring increasing significance in the investment choices of the pharmaceutical sector. The overall objective is to determine an optimal trade-off between the incentives for innovation, consumer protection, and value for money. However, price regulation is itself a...

In a recent article which appeared in this journal, Hoel and Saeter propose a model showing that welfare may be improved by introducing delay in public health care. In this note we argue that their model may be used as starting point because of their stringent assumptions. We suggest that the...

In this paper we use a simple theoretical model to compare alternative regulation regimes for the reimbursement of medical innovations when responses to a new treatment (effectiveness) are heterogeneous within the eligible population. We study two dimensions: i) efficiency in selecting...

Patient mobility is a key issue in the EU who recently passed a new law on patients' right to EU-wide provider choice. In this paper we use a Hotelling model with two regions that differ in technology to study the impact of patient mobility on health care quality, health care financing and...

Patient mobility is a key issue in the EU who recently passed a new law on patients' right to EU-wide provider choice. In this paper we use a Hotelling model with two regions that differ in technology to study the impact of patient mobility on health care quality, health care financing and...